Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

ALNY

ALNYLAM PHARMACEUTICALS, INC.

CIK 0001178670 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$236.22
↑ 6.92 (3.02%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Fundamentals, Ownership, Options; Risks: Technicals

Key stats

Market Cap
$31.61B
P/E Ratio
58.05
EPS
2.39
Dividend Yield
Not covered
52W Position
13%
Beta
0.35

Valuation multiples

Fwd P/E
26.32
PEG
0.43
P/B
23.34
P/S
7.47
EV/Revenue
7.07
ROE
40.2%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 13%
$197.81$495.55

Latest Financials

2025-12-31 FY
Revenue
$3.71B
Net Income
$313.75M
Total Assets
$4.97B
Free Cash Flow
$465.38M

Recent news